The mystery of motor asymmetry in Parkinson's disease

被引:310
作者
Djaldetti, Ruth
Ziv, Ilan
Melamed, Eldad
机构
[1] Rabin Med Ctr, Dept Neurol, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
D O I
10.1016/S1474-4422(06)70549-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The motor symptoms of Parkinson's disease are predominantly due to progressive degeneration of nigral dopaminergic neurons. In most cases there is a substantial asymmetry of clinical symptoms from disease onset, which occurs in sporadic and in hereditary forms of the disease. However, the mechanism of such unilaterality of symptom appearance is not understood. There is only sparse information about whether symptom-side predominance is genetically coded and determined years before symptom onset, or whether it is acquired and related to side differences in vulnerability of the degenerating neurons. In this Personal View we review data for unilaterality of symptoms at different disease stages. We also discuss several pathological, genetic, environmental, and toxic possibilities for explaining the mechanism of side predominance.
引用
收藏
页码:796 / 802
页数:7
相关论文
共 77 条
  • [1] PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
    Adams, JR
    van Netten, H
    Schulzer, M
    Mak, E
    Mckenzie, J
    Strongosky, A
    Sossi, V
    Ruth, TJ
    Lee, CS
    Farrer, M
    Gasser, T
    Uitti, RJ
    Calne, DB
    Wszolek, ZK
    Stoessl, AJ
    [J]. BRAIN, 2005, 128 : 2777 - 2785
  • [2] ADAMS RD, 1986, EXTRAPYRAMIDAL DISOR, P205
  • [3] FUNCTIONAL ARCHITECTURE OF BASAL GANGLIA CIRCUITS - NEURAL SUBSTRATES OF PARALLEL PROCESSING
    ALEXANDER, GE
    CRUTCHER, MD
    [J]. TRENDS IN NEUROSCIENCES, 1990, 13 (07) : 266 - 271
  • [4] PERMANENT HUMAN PARKINSONISM DUE TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) - 7 CASES
    BALLARD, PA
    TETRUD, JW
    LANGSTON, JW
    [J]. NEUROLOGY, 1985, 35 (07) : 949 - 956
  • [5] Benamer HTS, 2000, MOVEMENT DISORD, V15, P692, DOI 10.1002/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO
  • [6] 2-V
  • [7] Clinical features of parkinsonian patients with the α-synuclein (G209A) mutation
    Bostantjopoulou, S
    Katsarou, Z
    Papadimitriou, A
    Veletza, V
    Hatzigeorgiou, G
    Lees, A
    [J]. MOVEMENT DISORDERS, 2001, 16 (06) : 1007 - 1013
  • [8] Braak H, 1995, J NEURAL TRANSM-SUPP, P15
  • [9] PARKINSONS-DISEASE IN TWINS STUDIED WITH F-18 DOPA AND POSITRON EMISSION TOMOGRAPHY
    BURN, DJ
    MARK, MH
    PLAYFORD, ED
    MARAGANORE, DM
    ZIMMERMAN, TR
    DUVOISIN, RC
    HARDING, AE
    MARSDEN, CD
    BROOKS, DJ
    [J]. NEUROLOGY, 1992, 42 (10) : 1894 - 1900
  • [10] CALNE DB, 1994, NEUROLOGY, V44, P5